ADCM 4919/25 - Various Medications

The tender ADCM 4919/25 pertains to the procurement of various medications. This initiative is part of a broader effort to ensure the availability and accessibility of essential pharmaceutical products within the healthcare system. The tender includes a range of medication codes, specifically 1686825, 1687225, 1687025, 1686925, 1687325, 1686625, 1687425, which likely correspond to different types of medications required for public health services. Interested suppliers are expected to meet specific quality standards and regulatory requirements to ensure the efficacy and safety of the medications provided. The procurement process aims to enhance the supply chain for pharmaceuticals, ultimately improving health outcomes for the population served. It is crucial for bidders to review the detailed specifications and requirements outlined in the tender documents to ensure compliance. This tender is significant for stakeholders in the healthcare sector, including suppliers, healthcare providers, and government agencies, as it directly impacts the availability of critical medications. The location of the tender execution and the specific sector involved are not explicitly mentioned, but it is implied that this is a public health initiative aimed at improving medication access.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 110.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.